Catalent will add three additional commercial-scale viral vector manufacturing suites at its gene therapy campus in Harmans, Maryland. The latest investment at contract development manufacturing organization (CDMO) Catalent’s Harmans campus includes the construction of three additional multi-room commercial suites, as well as expanding storage capabilities for ultra-low temperature freezers, just-in-time inventory space,  and its water-for-injection infrastructure. “This latest expansion is to meet growing customer demand and is in anticipation of continued interest and growth in AAV and other gene therapies,”…

The mechanically complete facility in Strathclyde, Scotland will establish EnteroBiotix’s pipeline and provide end-to-end control of the supply chain, says firm. EnteroBiotix is a biopharmaceutical company focused on developing microbial therapeutics, which aim to treat debilitating diseases and infections associated with the function and structure of the gut microbiome. The mechanical completion of its purpose-built manufacturing donor-derived microbial therapeutic plant at Strathclyde Business Park, Scotland spans over 20,000 square feet and includes expansion of its corporate offices to support an…

CDMO GTP Bioways has invested $14 million into two biopharmaceutical production lines at its site in Toulouse, France. The French contract development manufacturing organization (CDMO), which specializes in the production of nanotherapies and biotherapies has said the first line will be dedicated to production using microbial systems such as bacteria and yeast. The first line will have a capacity of 300 L and is expected to be operational in the first quarter of 2023. The second manufacturing unit has been…

Novartis will further support production of the Pfizer-BioNTech COVID-19 vaccine through fill-finish capabilities at its Ljubljana, Slovenia site. Earlier this year, Swiss pharma giant Novartis signed an agreement to provide aseptic manufacturing services from its Stein, Switzerland, to support the production of Pfizer and BioNTech’s COVID-19 vaccine. The arrangement was described at the time as part of the “unprecedented level of collaboration” occurring across the industry, and nine months on such collaboration continues, with Novartis signing a new agreement to…

PTC Therapeutics has opened its gene therapy manufacturing facility in Hopewell, New Jersey set to support production and research operations. PTC leased the facility in July 2020 and has since invested around $20 million at the site to develop a biologics plant that supports gene therapy research and production. Now, the 220,500 square-foot facility is open and consists of office, manufacturing, and laboratory space. According to the firm, the Hopewell facility can handle process development and manufacturing services for PTC’s…

Cellectis has opened its clinical and commercial manufacturing facility in Raleigh, North Carolina making it a one-stop-shop company, says firm. France-headquartered Cellectis announced plans in March 2019 to construct a clinical and commercial production plant in Raleigh, North Carolina at a reported cost of $68 million to support its allogeneic universal chimeric antigen receptor t-cells (UCART) products. The 82,000 square-foot facility has been operational for a couple of months but Cellectis did an official opening earlier this month. The gene editing…